Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Report: Impact of drug combination of clopidogrel and pantoprazole In the prognosis of patients with transient ischemic attack.

Pakistan journal of pharmaceutical sciences - 1 Jan 2017

Lu Min

Abstract excerpt

The study aimed to investigate the impact of clopidogrel combined with proton pump inhibitors (PPI) pantoprazole treatment on the prognosis of patients with transient ischemic attack (TIA). A total of 478 cases of TIA patients treated with clopidogrel were randomly assigned half to clopidogrel combined with pantoprazole treatment and the control groups (clopidogrel treatment alone) from January 2012 to January...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 2-Pyridinylmethylsulfinylbenzimidazoles
Share to Clopidogrel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ischemic Attack, Transient

Share to Pharmacogenomic Variants

Share to Platelet Aggregation

Share to Platelet Function Tests

Share to Proton Pump Inhibitors

Share to Ticlopidine

Source

Identifiers

PMID: 28603135

Genes

ABCD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Report: Impact of drug combination of clopidogrel and pantoprazole In the prognosis of patients with transient ischemic attack.PMID 28603135Read ↗

Ticlopidine with Ginkgo Biloba extract: a feasible combination for patients with acute cerebral ischemia.Semantic proximity Read ↗

Dynamic changes and associated factors of clopidogrel resistance in patients after cerebral infarction.Semantic proximity Read ↗

A Comparison of the Effects of Ticagrelor and Clopidogrel in Patients with Acute ST-Segment Elevation Myocardial Infarction: A systematic review and Meta-analysisSemantic proximity Read ↗

Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke .Semantic proximity Read ↗

Whole blood dynamic platelet aggregation counting and 1-year clinical outcomes in patients with coronary heart diseases treated with clopidogrel.Semantic proximity Read ↗

[Impact of CYP2C19 genotypes on antiplatelet therapy among Chinese patients with acute myocardial infarction after percutaneous coronary intervention].Semantic proximity Read ↗

Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population.Semantic proximity Read ↗

Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial.Semantic proximity Read ↗

Clinical outcomes of generic versus brand-name clopidogrel for secondary prevention in patients with ischemic stroke: A nationwide retrospective cohort studySemantic proximity Read ↗

Factors that decrease the effectiveness of clopidogrel.Semantic proximity Read ↗

Safety considerations with the use of platelet inhibitors for elderly patients with non-ST- elevation acute coronary syndrome.Semantic proximity Read ↗

Efficacy and Mechanism of Panax Notoginseng in the Secondary Prevention for Stroke Patients with "Antiplatelet Drug Resistance"Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.